Publications by authors named "Kyohei Usami"
Article Synopsis
- The study aimed to understand how certain plaque characteristics detected by MDCT and CMR relate to periprocedural myocardial injury (PMI) in patients undergoing elective PCI.
- It found that patients with PMI had significantly more instances of high-risk plaque (HRP) and high-intensity plaque (HIP) compared to those without PMI, indicating these features can help predict the risk of injury during the procedure.
- The results suggest that MDCT and CMR are useful tools for identifying high-risk coronary lesions that could lead to PMI after elective PCI procedures.
Background: Nilotinib, a second-generation BCR-ABL tyrosine kinase inhibitor (TKI), is highly effective in the treatment of patients with chronic myeloid leukemia (CML), despite being more vasculotoxic than older TKIs such as imatinib. Herein, we present a case of nilotinib-associated vasospastic angina confirmed by an acetylcholine spasm provocation test.
Case Presentation: A 62-year-old CML patient treated with 300 mg nilotinib twice daily complained of several episodes of rest angina and was hospitalized at our institution.